IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ:IMCC), a medical cannabis company with operations in Israel and Germany, today announced the closing of a US$225,000 convertible note financing in a private placement with an institutional investor (the "Lender").

Pursuant to a note purchase agreement between the Company and Lender dated July 1, 2026 (the "July Note Purchase Agreement"), the Company issued the Lender a note in the principal amount of US$225,000, with an original issuance discount of 10% (the "July Note").

The Company intends to use the net proceeds from the July Note for general corporate purposes.